BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 8050579)

  • 1. Immunological significances of invariant chain from the aspect of its structural homology with the cystatin family.
    Katunuma N; Kakegawa H; Matsunaga Y; Saibara T
    FEBS Lett; 1994 Aug; 349(2):265-9. PubMed ID: 8050579
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Crystal structure of MHC class II-associated p41 Ii fragment bound to cathepsin L reveals the structural basis for differentiation between cathepsins L and S.
    Guncar G; Pungercic G; Klemencic I; Turk V; Turk D
    EMBO J; 1999 Feb; 18(4):793-803. PubMed ID: 10022822
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Major histocompatibility complex class II-associated p41 invariant chain fragment is a strong inhibitor of lysosomal cathepsin L.
    Bevec T; Stoka V; Pungercic G; Dolenc I; Turk V
    J Exp Med; 1996 Apr; 183(4):1331-8. PubMed ID: 8666891
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Potential sites for processing of the human invariant chain by cathepsins D and E.
    Kageyama T; Yonezawa S; Ichinose M; Miki K; Moriyama A
    Biochem Biophys Res Commun; 1996 Jun; 223(3):549-53. PubMed ID: 8687433
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mechanism and regulation of antigen processing by cathepsin B.
    Katunuma N; Matsunaga Y; Saibara T
    Adv Enzyme Regul; 1994; 34():145-58. PubMed ID: 7942272
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Essential role for cathepsin S in MHC class II-associated invariant chain processing and peptide loading.
    Riese RJ; Wolf PR; Brömme D; Natkin LR; Villadangos JA; Ploegh HL; Chapman HA
    Immunity; 1996 Apr; 4(4):357-66. PubMed ID: 8612130
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibitory fragment from the p41 form of invariant chain can regulate activity of cysteine cathepsins in antigen presentation.
    Mihelic M; Dobersek A; Guncar G; Turk D
    J Biol Chem; 2008 May; 283(21):14453-60. PubMed ID: 18362148
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Developmental regulation of invariant chain proteolysis controls MHC class II trafficking in mouse dendritic cells.
    Pierre P; Mellman I
    Cell; 1998 Jun; 93(7):1135-45. PubMed ID: 9657147
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A novel domain on HLA-DRbeta chain regulates the chaperone role of the invariant chain.
    Neumann J; Koch N
    J Cell Sci; 2006 Oct; 119(Pt 20):4207-14. PubMed ID: 16984974
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bm-CPI-2, a cystatin homolog secreted by the filarial parasite Brugia malayi, inhibits class II MHC-restricted antigen processing.
    Manoury B; Gregory WF; Maizels RM; Watts C
    Curr Biol; 2001 Mar; 11(6):447-51. PubMed ID: 11301256
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A cystatin F homologue from large yellow croaker (Larimichthys crocea) inhibits activity of multiple cysteine proteinases and Ii chain processing in vitro.
    Ao J; Li Q; Yang Z; Mu Y
    Fish Shellfish Immunol; 2016 Jan; 48():62-70. PubMed ID: 26578250
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cathepsin S, but not cathepsin L, participates in the MHC class II-associated invariant chain processing in large yellow croaker (Larimichthys crocea).
    Li Q; Ao J; Mu Y; Yang Z; Li T; Zhang X; Chen X
    Fish Shellfish Immunol; 2015 Dec; 47(2):743-50. PubMed ID: 26475363
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The proteolytic environment involved in MHC class II-restricted antigen presentation can be modulated by the p41 form of invariant chain.
    Fineschi B; Sakaguchi K; Appella E; Miller J
    J Immunol; 1996 Oct; 157(8):3211-5. PubMed ID: 8871612
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Salivary Tick Cystatin OmC2 Targets Lysosomal Cathepsins S and C in Human Dendritic Cells.
    Zavašnik-Bergant T; Vidmar R; Sekirnik A; Fonović M; Salát J; Grunclová L; Kopáček P; Turk B
    Front Cell Infect Microbiol; 2017; 7():288. PubMed ID: 28713775
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glycoprotein B from strain 17 of herpes simplex virus type I contains an invariant chain homologous sequence that binds to MHC class II molecules.
    Sievers E; Neumann J; Raftery M; SchOnrich G; Eis-Hübinger AM; Koch N
    Immunology; 2002 Sep; 107(1):129-35. PubMed ID: 12225371
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Thyroglobulin type-I-like domains in invariant chain fusion proteins mediate resistance to cathepsin L digestion.
    Hitzel C; Kanzler H; König A; Kummer MP; Brix K; Herzog V; Koch N
    FEBS Lett; 2000 Nov; 485(1):67-70. PubMed ID: 11086167
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Delivery of nascent MHC class II-invariant chain complexes to lysosomal compartments and proteolysis of invariant chain by cysteine proteases precedes peptide binding in B-lymphoblastoid cells.
    Morton PA; Zacheis ML; Giacoletto KS; Manning JA; Schwartz BD
    J Immunol; 1995 Jan; 154(1):137-50. PubMed ID: 7995933
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Production and characterization of two variants of human cystatin SA encoded by two alleles at the CST2 locus of the type 2 cystatin gene family.
    Saitoh E; Minaguchi K; Ishibashi O
    Arch Biochem Biophys; 1998 Apr; 352(2):199-206. PubMed ID: 9587407
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Invariant chain processing is independent of cathepsin variation between primary human B cells/dendritic cells and B-lymphoblastoid cells.
    Reich M; Zou F; Sieńczyk M; Oleksyszyn J; Boehm BO; Burster T
    Cell Immunol; 2011; 269(2):96-103. PubMed ID: 21543057
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mediation by HLA-DM of dissociation of peptides from HLA-DR.
    Sloan VS; Cameron P; Porter G; Gammon M; Amaya M; Mellins E; Zaller DM
    Nature; 1995 Jun; 375(6534):802-6. PubMed ID: 7596415
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.